Sign In
Buy AXSM
$212.17
+1.13 (+0.535%)
At Close: Aug 04, 2026
Axsome: Teva's ANDA Is No Surprise And No Big Deal
11:06am, Monday, 20'th Feb 2023
Teva filed an ANDA challenge against Auvelity four months after approval. The filing defines, for me, the hurdles generics will face in challenging Axsome's huge patent estate.
Axsome Therapeutics (AXSM) Stock Falls as Teva Pursues Generic Depression Drug
10:34am, Monday, 13'th Feb 2023
Axsome Therapeutics (NASDAQ: AXSM ) stock is taking a beating on Monday as rival Teva Pharmaceutical (NYSE: TEVA ) prepares a generic depression drug. According to a filing with the U.S. Securities an
Axsome's stock falls after disclosing Teva's plans to market generic Auvelity
08:01am, Monday, 13'th Feb 2023
Shares of Axsome Therapeutics Inc. AXSM, -0.27% tumbled about 10.0% in premarket trading on Monday after the company said in a securities filing that Teva Pharmaceutical Industries Ltd. TEVA, +4.48% i
2 Biotech Stocks You Can Buy and Hold for the Next Decade
09:00am, Sunday, 12'th Feb 2023
These companies could grow in prominence in the coming years.
3 Surefire Growth Stocks You Can Buy Right Now
02:31pm, Saturday, 11'th Feb 2023
Maybe there's no such thing as a sure thing. But these stocks could come close.
Axsome Therapeutics to Present at the SVB Securities Global Biopharma Conference
07:00am, Tuesday, 07'th Feb 2023
NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system
Axsome Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on February 27
07:00am, Tuesday, 31'st Jan 2023
Axsome to host conference call and webcast on Monday, Feb. 27, 2023, at 8:00 a.m. ET Axsome to host conference call and webcast on Monday, Feb. 27, 2023, at 8:00 a.m. ET
The Ultimate Growth Stocks to Buy With $300 Right Now
07:25am, Sunday, 29'th Jan 2023
These three companies should deliver inflation-busting long-term growth.
2 Promising New Growth Stocks to Watch in 2023
05:30am, Monday, 23'rd Jan 2023
These stocks have plenty of room to run.
2 Stocks That Could Double Your Money in 2023
10:07am, Saturday, 07'th Jan 2023
These biotechs could crush the market, but there is more to the story.
These Stocks Jumped 100% and 30% Last Year. Here's Why They're Still a Buy.
05:30am, Saturday, 07'th Jan 2023
These stocks look cheap if you take a long-term view.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
10:32am, Thursday, 05'th Jan 2023
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Axsome: A Lot More Upside In 2023
07:10am, Monday, 02'nd Jan 2023
Axsome has one pending approval and two pending NDAs coming up in 2023. They are adequately funded, if not very strongly.
100 Best Stocks Of 2022: Fossil Fuel Ignites, Solar Shines, Meds Make Miracles
06:42pm, Friday, 30'th Dec 2022
Historic 2022 inflation lifted energy and value stocks while sinking growth plays. The post 100 Best Stocks Of 2022: Fossil Fuel Ignites, Solar Shines, Meds Make Miracles appeared first on Investor's
Axsome (AXSM) Rides on New Drug Approval & Sunosi Buyout
11:17am, Friday, 30'th Dec 2022
Axsome (AXSM) receives FDA approval for Auvelity to treat major depressive disorder in August. The Sunosi deal and promising pipeline bode well.
